AMRI (Albany Molecular Research Inc.) is a contract research and manufacturing organization that provides drug discovery, development, cGMP manufacturing and aseptic fill and finish to the pharmaceutical and biotechnology industries. Founded over 27 years ago, AMRI operates in the United States, Europe and Asia, with its headquarters located in Albany, New York. AMRI has announced deals and collaborations with such companies as Pfizer Inc., Merck & Co., Eli Lilly and Co., Takeda, Genentech, Bristol-Myers Squibb Co. and GE.

Temasek Life Sciences Laboratory (TLL) was established in August 2002 and as a Singapore Non Profit Philanthropic Research Organisation focusing primarily on understanding the cellular mechanisms that underlie the development and physiology of plants, fungi and animals which provides foundation for biotechnology innovation.

Kaneka Corp. engages in the manufacture and sale of chemicals, synthetic resins, and plastics. It operates through the following segments: Material Solutions, Quality of Life Solutions, Health Care Solutions, Nutrition Solutions and Others. The Material Solutions segment covers biodegradable polymers, materials that support the development of social infrastructure and mobility which includes the weight reduction and fuel efficiency improvement. The Quality of Life Solutions segment handles energy saving needs such as housing and living infrastructure, and development of Internet of things (IoT) and artificial intelligence (AI). The Health Care Solutions segment offers solutions through the fusion of devices and medicines, and develops healthcare business based on biopharmaceuticals and regenerative and cellular medicines. The Nutrition Solutions segment provides materials and supplement solutions to food production support in livestock and fishery industries. The Others segment provides agency services for property and life insurance. The company was founded on September 1, 1949 and is headquartered in Osaka, Japan.

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Daicel Corp. engages in the manufacture and sale of chemical products. It operates through the following segments: Cellulosic Derivatives, Organic Chemicals, Plastics, Pyrotechnic Devices, and Others. The Cellulosic Derivatives segment engages in the production of various cellulosic derivatives such as cellulose acetate, acetate tow for cigarette filters, and water-soluble polymers. The Organic Chemicals segment offers various solvents and fine chemicals; acetic acid, and chiral columns used for separation of optical isomers. The Plastic segment develops unique products for numerous industrial sectors such as engineering plastics, polymer alloys and cyclic-olefin copolymers; and also develops a variety of plastic processed products such as polystyrene sheets, formed trays, and functional films. The Pyrotechnic Devices segment provides motor vehicle safety devices, airbag inflators, aerospace and defense systems. The Others segment includes membrane and warehousing business. The company was founded on September 8, 1919 and is headquartered in Osaka, Japan.

Part of Lonza Group AG, Lonza Ltd. is a company headquartered in Basel, Switzerland, that supplies chemicals for pharmacy industry.

Beijing Dabeinong Technology Group Co., Ltd. engages in the manufacture, process, and sale of feed and seed products. It also deals with the import and export of animal health and plant protection products. The company was founded by Gen Huo Shao on December 28, 1993 and is headquartered in Beijing, China.

Fujian Dabei Nonghuayou Aquatic Technology Group Co., Ltd., established on 2013-01-17, Business scope includes general items:Technology promotion and application services;Feed Raw Material Sales;Wholesale of aquatic products;Animal Husbandry and Fishery Feed Sales;Bio-feed R&D;Information Consulting Service(Not including licensing information consulting services);Fishing Tackle Sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Feed Additive Sales;fertilizer sales;Technical extension services;Research and development of bio-based materials technology;Manufacturing of bio-based materials;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Bio-organic fertilizer research and development;Fertilizer sales;water pollution control;Manufacture of special equipment for environmental protection;Environmental protection special equipment sales;Eco-environmental material manufacturing;Eco-environmental material sales;Water Environment Pollution Prevention and Control Services;Grain Purchase(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license). licensed items:feed production;Veterinary drug production;Veterinary drug business;Aquatic seed production;aquaculture;Feed additive production;fertilizer production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Tokuyama Corp. engages in the manufacture and sale of inorganic and organic industrial chemicals, synthetic resins, cement, and construction materials. It operates through the following segments: Chemicals, Specialty Products, Cement, Life and Amenity, and Others. The Chemicals segment produces and markets caustic soda, soda ash, and chlorine. The Specialty Products segment covers the development and sale of polycrystalline silicon, fumed silica, precipitated silica, aluminium nitride, pharmaceutical ingredients, and intermediates. The Cement segment handles the production and distribution of cement and cement related products that include ordinary Portland cement, blast-furnace slag cement, ready-mixed concrete, cement-type stabilizer, and waste treatments. The Life and Amenity segment comprises of polyolefin films, plastic window sashes, medical diagnosis systems, dental materials and equipment, gas sensors, and ion exchange membranes. The company was founded by Katsujiro Iwai on February 16, 1918 and is headquartered in Tokyo, Japan.

Beijing Kehuitong Smart Technology Co., Ltd., established on 2014-07-08, Business scope includes technology development,technology transfer,technical consulting,Technical Services;Sales of machinery and equipment.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

The Group's principal activity is to produce pharmaceuticals and chemicals. The operations are carried out through the following divisions: Pharmaceuticals; Bio chemical; Chemicals; Food and Other. Pharmaceuticals include ethical drugs, bulk pharmaceuticals and biological research. Bio chemicals deal with biochemical diagnostic reagents, animal health products, agrochemicals and fertilizers. Chemicals includes solvents, plasticizes and their raw materials, detergent raw materials and specialty chemicals. Food includes alcoholic beverages, alcohol, seasonings, confectionery, baking ingredients and processed foods. Others include wholesale, commodity distribution and installation of facilities.

Antibi��ticos SA is a company headquartered in Le��n, Spain, that manufactures antibiotics and other pharmaceutical preparations. Black Toro Capital Partners (ES) acquired Antibi��ticos SA from Grupo Enerthi on September 17, 2014 for $11.65 million.

Angel Yeast Co., Ltd. engages in the production and sales of yeast and deep-processed products, biological products, food additives, soy products, dairy products, condiments, and food products. Its business scope includes production and sales of yeast and yeast products for food processing, condiments, beverages, health food, and food additives; research and development, production and sales of formulas for special medical purposes and special dietary foods; and research, development, production and sales of biochemical products and raw materials for daily chemical products. The company was founded on March 25, 1998 and is headquartered in Yichang, China.

Zhejiang Huarui Biotechnology Co., Ltd., established on 2017-12-01, Business scope includes general items:Food Additive Sales;Feed Additive Sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Fermentation process optimization technology research and development;R&D of industrial enzyme preparations;Technology intermediary service;Biochemical product technology research and development;Medical Research and Experimental Development;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Cosmetics Wholesale;Feed Raw Material Sales;food sales(Only sell prepackaged food);Food Internet Sales(Only sell prepackaged food);Healthy food(prepackaged)Sales;Sales of formula food for special medical purposes;Import and export;Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Food additive production;Feed additive production;Health food production;Cosmetic production;Drug import and export;food sales;food production;Import of new chemical substances;feed production;Inspection and testing service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Engages in developing, producing and selling pharmaceutical and chemical products

AMR Technology, Inc. is an American private company that provides chemistry research and drug development services and manufactures pharmaceutical preparations.

Takasago International Corp. engages in the manufacture and sale of flavors, fragrances, aroma ingredients, and fine chemicals. It operates through the following regional segments: Japan, America, Europe, and Asia. All of the segments handle flavor, fragrances, and aroma ingredients. The Japan segment also deals with fine chemicals and offer real estate leasing and other services. The America Segment also sells fine chemicals. The company was founded by Nanko Kaisho on February 09, 1920 and is headquartered in Tokyo, Japan.

Huai'an Huaiyin Dabei Agricultural Feed Co., Ltd., established on 2000-08-10, The business scope includes compound feed,concentrated feed,Additive premix feed production,Grain Purchase,compound feed,premix feed,Concentrated Feed Sales,Biotechnology R&D,Production,Sales,Research and development of agricultural microbial agents,Production,Sales,Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export),Veterinary Chemicals,Chinese medicine preparation,Topical Insecticides,disinfectant,Microbial preparations for aquatic environment improvement(except dangerous goods)Development,Production,operate,Self-owned factory lease,Pig breeding and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)